What Changed at Xsolis

Every material change AI Health Index has tracked at Xsolis: new modules, model and architecture updates, clinical evidence, regulatory status, security certifications, and integration depth. Each entry states what changed, cites its source, and carries our read on what it means for a buyer. The graded assessment of this vendor across all fifteen capability axes sits on its index profile.

Funding rounds, valuations, and awards are not product changes and are not logged here. Acquisitions appear only where there is direct product impact.

Impact
Type
1 entry
Showing changes for Xsolis only.Show the full log

September 2026

X
Xsolis
Sep 1, 2026
MediumPartially Verified
Product / capability

Xsolis launched GenAI Peer-to-Peer Clinical Synopsis as an add on inside Dragonfly Advise. It reads longitudinal EMR data including labs, vitals and nursing notes, and generates a structured synopsis highlighting severity indicators and medical necessity rationale ahead of a peer to peer denial review.

Our read

The vendor puts the manual version of this task at 15 to 20 minutes of chart reconstruction inside a 24 to 72 hour regulatory window, which is a specific enough claim to test against a physician advisor's own calendar. The risk to check in evaluation is what the synopsis omits, since a medical necessity argument built from a summary is only as good as the exclusions nobody sees.

Related axis: AI CentralityTrade pressView source